Age, Biography and Wiki

Victor Velculescu was born on 16 August, 1970 in Bucharest, Romania, is an A romanian emigrant to the United States. Discover Victor Velculescu's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is he in this year and how he spends money? Also learn how he earned most of networth at the age of 53 years old?

Popular As N/A
Occupation N/A
Age 53 years old
Zodiac Sign Leo
Born 16 August 1970
Birthday 16 August
Birthplace Bucharest, Romania
Nationality United States

We recommend you to check the complete list of Famous People born on 16 August. He is a member of famous with the age 53 years old group.

Victor Velculescu Height, Weight & Measurements

At 53 years old, Victor Velculescu height not available right now. We will update Victor Velculescu's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.

Physical Status
Height Not Available
Weight Not Available
Body Measurements Not Available
Eye Color Not Available
Hair Color Not Available

Who Is Victor Velculescu's Wife?

His wife is Delia Velculescu

Family
Parents Not Available
Wife Delia Velculescu
Sibling Not Available
Children Not Available

Victor Velculescu Net Worth

His net worth has been growing significantly in 2023-2024. So, how much is Victor Velculescu worth at the age of 53 years old? Victor Velculescu’s income source is mostly from being a successful . He is from United States. We have estimated Victor Velculescu's net worth, money, salary, income, and assets.

Net Worth in 2024 $1 Million - $5 Million
Salary in 2024 Under Review
Net Worth in 2023 Pending
Salary in 2023 Under Review
House Not Available
Cars Not Available
Source of Income

Victor Velculescu Social Network

Instagram
Linkedin
Twitter
Facebook
Wikipedia Victor Velculescu Wikipedia
Imdb

Timeline

1970

Victor E. Velculescu (born August 16, 1970) is a Professor of Oncology and Co-Director of Cancer Biology at Johns Hopkins University School of Medicine.

He is internationally known for his discoveries in genomics and cancer research.

Velculescu was born in Bucharest, Romania and moved with his family to Westlake Village, California at the age of seven.

1992

He began molecular biology research as an undergraduate at Stanford University, graduating with honors and distinction in biological sciences in 1992.

Velculescu completed his M.D. degree, a Ph.D. in human genetics and molecular biology, and postdoctoral studies at the Johns Hopkins School of Medicine where he remains on the faculty.

He is married to Delia Velculescu, an economist and the current IMF mission chief in Greece.

Velculescu and members of his research group have pioneered approaches for discovering molecular alterations in human cancer and applying these discoveries to improve the diagnosis and treatment of cancer.

1995

In 1995 Velculescu developed SAGE (serial analysis of gene expression), a gene expression technology for the global and quantitative measurement of gene activity.

The SAGE approach provided some of the first insights into gene expression patterns in eukaryotic cells and the identification of gene expression patterns in human cancer.

1997

These studies led Velculescu to coin the term transcriptome in a 1997 paper to describe the comprehensive gene expression patterns that could now be analyzed.

SAGE contributed to the development of next-generation sequencing methods used for genome-wide expression analyses.

2000

In the early 2000s, Velculescu and members of his laboratory devised new technologies for characterizing the cancer genome.

These included digital karyotyping, which allows for quantitative characterization of amplifications and deletions at the DNA level.

This approach provided the underlying methodology for next-generation sequencing analyses to detect chromosomal abnormalities in human cancer as well as in prenatal genetic testing.

In parallel, Velculescu was an early developer of methods for high-throughput sequencing of human cancer, which his group used to identify the PIK3CA gene as one of the most highly mutated cancer genes.

2005

Starting in 2005, Velculescu extended these approaches, and together with Bert Vogelstein, Ken Kinzler and other colleagues at Johns Hopkins performed the first sequence analysis of the coding genome in human cancers, including breast, colorectal, brain, and pancreatic cancers.

His group also led the effort to sequence the first pediatric tumor genome for medulloblastoma.

These studies defined the genomic landscapes of human cancers and identified alterations in a variety of genes and pathways not previously known to be involved in tumorigenesis, including the IDH1 and IDH2 genes in gliomas, and chromatin modifying genes MLL2/3 and ARID1 in medulloblastomas, neuroblastomas and other tumor types.

2010

In 2010, Velculescu and his group developed the PARE (personalized analysis of rearranged ends) technology that can help detect genomic tumor biomarkers circulating in the blood to enable the monitoring and personalized treatment of human cancer.

Using this approach, his laboratory performed the first whole-genome analysis detecting chromosomal alterations in the blood of cancer patients.

Velculescu co-founded the cancer genomics company Personal Genome Diagnostics (PGDx) in 2010 to bring individualized cancer genome analyses to patients, physicians, researchers and drug developers.

2011

PGDx was the first clinical laboratory to provide whole-exome sequencing for cancer patients in 2011.